Doing Your DD, Doesn't mean just reading the last article written about ACAD, it's tracking and knowing what has been also written in the past. If your new to ACAD, you should know that management has confirmed that they are in talks with big pharmas. Link:
The StreetInsider May 6, 2013 Analyst Thomas Wei is positive on developments for Acadia's pimavanserin.
"We had an opportunity to meet with ACAD management recently and are incrementally encouraged bycommentary on manufacturing timelines for pimavanserin, the rate limiting step to filing, as well as commentary on outside interest in pimavanserin from pharma companies," the analyst said.